• Introduction, Preactivity and Polling Questions
• Understanding the Link Between Narcolepsy and Idiopathic Hypersomnia and Cardiovascular Risk
• Evidence-Based Recommendations for CV Risk Mitigation
• Individualized Patient Management
• Conclusion and Summary of Learning Points
• Audience Q&A

Goal Statement
The goal of this activity is to improve the knowledge and competence of HCPs on the topic of cardiovascular risk and narcolepsy to optimize treatment for patients with narcolepsy.

Target Audience
This activity is intended for healthcare professionals who treat patients with narcolepsy, including sleep specialists, pulmonologists, psychiatrists, neurologists, primary care physicians, nurse practitioners, nurses, pharmacists, and physician associates.

Learning Objectives
Upon completion of this activity, participants should be able to:

• Summarize the association between narcolepsy, idiopathic hypersomnia, and cardiovascular risk, with a focus on underlying pathophysiological mechanisms

• Evaluate current evidence-based recommendations for minimizing cardiovascular risks in patients with narcolepsy and idiopathic hypersomnia

• Design individualized treatment plans for patients with narcolepsy and idiopathic hypersomnia that incorporate cardiovascular risk management alongside symptom control